Navigation Links
Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
Date:5/22/2008

SEATTLE, May 22 /PRNewswire/ -- Amnis Corporation announced today the commercial release of its Extended Depth of Field (EDF(TM)) option for the ImageStream system. This technology breaks through classical depth of field limitations of high resolution optical systems, thereby improving the performance of the ImageStream system and enabling new applications including high speed analysis of fluorescence in-situ hybridization (FISH). The EDF option can be installed at time of manufacture or in the field to allow the existing customer base to take advantage of this new capability.

"The EDF option uses a combination of specialized optics and unique image processing algorithms to project all structures within the cell onto one crisp plane of focus," said William Ortyn, Amnis' Chief Operating Officer. "Until now this could only be accomplished via conventional confocal image stacking techniques which are very slow and tend to suffer from photo bleaching. The ImageStream with EDF is unhindered by photo bleaching and operates at rates close to 1000 times faster than confocal microscopy. The resulting imagery and analysis capabilities are unparalleled in the cell analysis space setting the stage for the development of fundamentally new research and clinical applications based on the ImageStream platform."

"To create the EDF upgrade we combined WaveFront Coded(TM) technology from [OmniVision-CDM Optics] with our own optimized image deconvolution algorithms, with striking results," said David Basiji, Ph.D., Amnis' President and CEO. "In addition to the optical benefits, the EDF option triples the data collection rate by allowing the instrument to be operated with a larger core stream diameter. One of the most important applications the ImageStream with EDF can now address is FISH in suspension (FISHIS(R)). Counting FISH spots accurately requires that all spots be in focus, no matter where they are in the nucleus ... EDF technology, combined with the tremendous speed and sensitivity of the ImageStream system, will make high throughput FISHIS a reality. With the recent release of IDEAS 3.0 and the current release of the EDF option, the Company continues to make excellent progress in advancing the technological capabilities of our product line.

Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets the ImageStream system for high speed imaging of cells in flow. The system generates over 100,000 high resolution cell images per minute with fluorescence sensitivity better than standard flow cytometry. The ImageStream is supported by the IDEAS(R) image analysis package, a highly sophisticated yet easy to use tool for processing hundreds of thousands of images at a time. The software package enables advanced research applications in hematology, immunology and oncology, and provides a critical foundation for the company's clinical applications development.


'/>"/>
SOURCE Amnis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
2. Amnis Announces Release of Powerful New Image Data Analysis Software
3. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):